Your browser is no longer supported. Please, upgrade your browser.
Settings
AVDL Avadel Pharmaceuticals plc daily Stock Chart
AVDL [NASD]
Avadel Pharmaceuticals plc
Index- P/E- EPS (ttm)-1.14 Insider Own0.30% Shs Outstand44.31M Perf Week-11.38%
Market Cap65.58M Forward P/E- EPS next Y-0.51 Insider Trans-8.42% Shs Float35.64M Perf Month-27.80%
Income-43.20M PEG- EPS next Q-0.46 Inst Own56.30% Short Float4.92% Perf Quarter-34.80%
Sales117.10M P/S0.56 EPS this Y-296.30% Inst Trans1.48% Short Ratio11.49 Perf Half Y-66.36%
Book/sh0.07 P/B21.14 EPS next Y76.60% ROA- Target Price3.00 Perf Year-79.04%
Cash/sh2.25 P/C0.66 EPS next 5Y-8.00% ROE- 52W Range1.56 - 7.97 Perf YTD-42.64%
Dividend- P/FCF- EPS past 5Y- ROI-63.10% 52W High-81.43% Beta1.82
Dividend %- Quick Ratio3.10 Sales past 5Y89.90% Gross Margin85.30% 52W Low-5.13% ATR0.16
Employees169 Current Ratio3.30 Sales Q/Q-39.90% Oper. Margin-89.70% RSI (14)30.98 Volatility7.46% 8.63%
OptionableYes Debt/Eq48.29 EPS Q/Q- Profit Margin- Rel Volume1.26 Prev Close1.57
ShortableYes LT Debt/Eq48.25 EarningsMar 15 BMO Payout- Avg Volume152.71K Price1.48
Recom3.00 SMA20-21.90% SMA50-35.44% SMA200-63.76% Volume192,187 Change-5.73%
Feb-08-19Downgrade Ladenburg Thalmann Buy → Neutral
Mar-20-19 11:14AM  Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision Zacks
Mar-15-19 07:18AM  Avadel: 4Q Earnings Snapshot Associated Press -16.50%
07:00AM  Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Mar-07-19 08:00AM  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire +9.73%
Feb-07-19 01:41PM  Avadel Pharmaceuticals Clarifies Announcement of Corporate Restructuring GlobeNewswire -22.15%
12:51PM  [$$] Avadel Specialty Pharmaceuticals Files for Chapter 11 Bankruptcy The Wall Street Journal
08:00AM  Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development Program GlobeNewswire
Jan-23-19 10:30AM  Sleep Normal campaign urges Americans to end frequent nighttime urination and stop settling for nights of bad sleep GlobeNewswire
Jan-18-19 09:34AM  Read This Before Selling Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Simply Wall St.
Jan-03-19 08:30AM  Avadel Pharmaceuticals Announces Changes to Management Team and Board of Directors GlobeNewswire +10.07%
Dec-24-18 10:08AM  Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA Zacks -10.45%
Dec-11-18 08:30AM  Avadel Pharmaceuticals Appoints Kevin Kotler to the Companys Board of Directors GlobeNewswire
07:35AM  Report: Developing Opportunities within Eaton Vance, IDT, Hemispherx BioPharma, Edgewell Personal Care, Rockwell Medical, and Avadel Pharmaceuticals Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-29-18 09:00AM  As Waking Up Multiple Times a Night to Urinate Can Lead to Memory Deficits, Obesity, Lowered Sex Drive, Falls and Depression, a New Council Urges Awareness and Action GlobeNewswire
Nov-05-18 08:13AM  Avadel: 3Q Earnings Snapshot Associated Press -23.88%
08:00AM  Avadel Pharmaceuticals Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-29-18 08:30AM  Avadel Presents Data on Quality of Life Improvement in Patients on NOCTIVA at American Urological Association Western Annual Meeting GlobeNewswire
Oct-25-18 07:30AM  Avadel Pharmaceuticals to Report Third Quarter 2018 Financial Results GlobeNewswire
Oct-16-18 08:15AM  New Research Coverage Highlights Dorian LPG, Avadel Pharmaceuticals, Pieris Pharmaceuticals, Resolute Energy, American Public Education, and THL Credit Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-15-18 08:30AM  Avadel Pharmaceuticals Presents Data for NOCTIVA at 2018 American Urogynecologic Society Annual Scientific Meeting GlobeNewswire
Sep-28-18 08:30AM  Avadel Pharmaceuticals Announces Journal of Urology Publication of Phase 3 Data on NOCTIVA GlobeNewswire +7.60%
Sep-25-18 07:30AM  Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare Conference GlobeNewswire
Sep-12-18 08:30AM  The medical condition 72 percent of Americans dont know about is stealing sleep and disrupting lives, survey shows GlobeNewswire
Sep-06-18 05:54PM  Brandes Investments Expands Stake in Avadel Pharmaceuticals GuruFocus.com
Aug-30-18 07:30AM  Avadel Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference GlobeNewswire
Aug-29-18 08:35AM  New Data on NOCTIVA Presented at the 2018 International Continence Society Meeting GlobeNewswire +6.56%
Aug-17-18 08:15AM  Analysis: Positioning to Benefit within Armstrong Flooring, U.S. Global Investors, Aqua Metals, Clearside Biomedical, EP Energy, and Avadel Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-07-18 08:00AM  Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call ACCESSWIRE -13.62%
07:42AM  Avadel: 2Q Earnings Snapshot Associated Press
07:30AM  Avadel Pharmaceuticals Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-19-18 07:45AM  Breakfast Technical Briefing on Avid Bioservices and Three Other Additional Biotech Stocks ACCESSWIRE
Jul-17-18 07:33AM  Avadel Pharmaceuticals to Report Second Quarter 2018 Results GlobeNewswire
Jun-27-18 12:37PM  Should You Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Continue Delivering An ROE Of 34.61%? Simply Wall St.
May-31-18 04:01PM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
08:30AM  Free Technical Insights on CASI Pharma and Three Other Biotech Stocks ACCESSWIRE
08:30AM  Analysis: Positioning to Benefit within Avadel Pharmaceuticals, Abeona Therapeutics, BanColombia S.A, Aercap Holdings N.V, Kite Realty Group Trust, and Credicorp Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-18-18 11:00AM  Avadel to Present Late-Breaker Data and Product Theater Forum at the 2018 American Urological Association Annual Meeting GlobeNewswire
May-02-18 09:26AM  Avadel: 1Q Earnings Snapshot Associated Press
07:30AM  Avadel Pharmaceuticals Reports First Quarter 2018 Results GlobeNewswire
May-01-18 09:43AM  Avadel Launches NOCTIVA, the First and Only FDA-Approved Treatment for Nocturia Due to Nocturnal Polyuria GlobeNewswire
Apr-30-18 04:01PM  Avadel Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference GlobeNewswire
Apr-24-18 07:30AM  Avadel Pharmaceuticals to Report First Quarter 2018 Results GlobeNewswire
Apr-17-18 03:41PM  Avadel Pharmaceuticals plc (NASDAQ:AVDL): Whats The Analyst Consensus Outlook? Simply Wall St.
Apr-06-18 07:55AM  Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJ's Restaurants What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-03-18 07:30AM  Avadel Pharmaceuticals Announces Acceptance of Late-Breaker Presentation for NOCTIVA at the 2018 American Urological Association GlobeNewswire
Mar-22-18 07:30AM  Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer GlobeNewswire
Mar-19-18 09:37AM  Jazz Pharma Upgraded On Bullish Pipeline Forecast, Earnings Growth Visibility, M&A Potential Benzinga
Mar-09-18 08:10AM  Detailed Research: Economic Perspectives on McDonald's, TriCo Bancshares, Polaris Industries, Nuance Communications, Avadel Pharmaceuticals, and Power Integrations What Drives Growth in Today's Competitive Landscape GlobeNewswire
07:30AM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Mar-08-18 09:45AM  Avadel reports 4Q loss Associated Press -10.26%
07:30AM  Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
Feb-26-18 07:30AM  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Results GlobeNewswire +5.17%
Feb-14-18 04:34PM  Here's Why Avadel Pharmaceuticals Dropped as Much as 13.3% Today Motley Fool -14.46%
08:27AM  Avadel Pharmaceuticals Announces Pricing of $125.0 Million 4.50% Exchangeable Senior Notes due 2023 GlobeNewswire
Feb-13-18 04:28PM  Avadel Pharmaceuticals Announces Proposed Exchangeable Senior Notes Offering GlobeNewswire
Feb-12-18 06:18PM  Charles Brandes Subscribes to Comcast in 4th Quarter GuruFocus.com
09:07AM  Avadel Pharmaceuticals Announces Divestiture of Pediatric Business GlobeNewswire
Feb-02-18 10:39AM  Why Avadel Pharmaceuticals plcs (NASDAQ:AVDL) Ownership Structure Is Important Simply Wall St.
Jan-25-18 08:13PM  Avadel Pharmaceuticals plc (NASDAQ:AVDL): Is Now The Time To Bet On Healthcare? Simply Wall St.
Jan-21-18 09:02AM  January Undervalued Opportunities TICC Capital And More Simply Wall St.
Jan-17-18 05:37PM  Should You Be Tempted To Buy Avadel Pharmaceuticals plc (NASDAQ:AVDL) At Its Current PE Ratio? Simply Wall St.
Jan-12-18 07:30AM  Blog Exposure FDA Grants Orphan Drug Designation to Avadel Pharmas FT 218 For Treatment Of Narcolepsy ACCESSWIRE +7.46%
Jan-10-18 07:30AM  Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 for the Treatment of Narcolepsy GlobeNewswire
Dec-29-17 07:30AM  Avadel Pharmaceuticals Issues 2018 Corporate Outlook GlobeNewswire
Dec-25-17 09:03AM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-20-17 08:35AM  Does Avadel Pharmaceuticals plcs (NASDAQ:AVDL) CEO Pay Reflect Performance? Simply Wall St.
Dec-16-17 08:02AM  Top Cheap Stocks This Week Simply Wall St.
Dec-11-17 11:18AM  Should You Expect Avadel Pharmaceuticals plc (AVDL) To Continue Delivering An ROE Of 121.91%? Simply Wall St.
Nov-27-17 07:30AM  Avadel Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-14-17 08:02AM  Value-Adding Discounted Stocks To Buy Now Simply Wall St.
Nov-10-17 07:00AM  Featured Company News - Alkermes Presents Positive Pre-Clinical Data On Immuno-Oncology Drug Candidate ALKS 4230 ACCESSWIRE
Nov-08-17 08:25AM  Avadel posts 3Q profit Associated Press
07:30AM  Avadel Pharmaceuticals Reports Third Quarter 2017 Results GlobeNewswire
Nov-06-17 07:30AM  Avadel Pharmaceuticals to Host Analyst and Investor Meeting GlobeNewswire
Oct-20-17 04:05PM  Avadel Pharmaceuticals to Report Third Quarter 2017 Results GlobeNewswire
Oct-19-17 04:57PM  What does Avadel Pharmaceuticals plcs (AVDL) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Oct-05-17 07:30AM  Avadel Pharmaceuticals Announces Data Presentation for Noctiva at The American Urogynecologic Societys Annual Scientific Meeting GlobeNewswire
Oct-03-17 08:46AM  At $10.73, Is Avadel Pharmaceuticals plc (AVDL) A Buy? Simply Wall St.
Sep-13-17 07:30AM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Sep-05-17 04:05PM  Avadel Pharmaceuticals Enters into Exclusive License Agreement for Noctiva GlobeNewswire
Aug-29-17 07:30AM  Avadel Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference GlobeNewswire
Aug-17-17 04:05PM  Avadel Pharmaceuticals Enters into Exclusive Negotiations with Serenity Pharmaceuticals for Noctiva GlobeNewswire
Aug-08-17 10:23PM  Avadel posts 2Q profit Associated Press
07:30AM  Avadel Pharmaceuticals Reports Second Quarter 2017 Results GlobeNewswire
Jul-20-17 08:30AM  Avadel Pharmaceuticals to Report Second Quarter 2017 Results GlobeNewswire
Jul-13-17 03:32PM  ETFs with exposure to Avadel Pharmaceuticals Plc : July 13, 2017 Capital Cube
Jul-03-17 02:54PM  ETFs with exposure to Avadel Pharmaceuticals Plc : July 3, 2017 Capital Cube
Jun-16-17 03:25PM  ETFs with exposure to Avadel Pharmaceuticals Plc : June 16, 2017 Capital Cube
Jun-14-17 09:48AM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
May-30-17 04:03PM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
May-17-17 09:30AM  Avadel Pharmaceuticals Supports the Narcolepsy Network's 5th Annual DREAM BIG Walk GlobeNewswire
May-09-17 08:45AM  Investor Network: Avadel Pharmaceuticals plc to Host Earnings Call Accesswire +6.81%
07:59AM  Avadel posts 1Q profit Associated Press
07:30AM  Avadel Pharmaceuticals Reports First Quarter 2017 Results GlobeNewswire
May-03-17 03:36PM  ETFs with exposure to Avadel Pharmaceuticals Plc : May 3, 2017 Capital Cube
May-02-17 02:54PM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q4, 2016 By the Numbers : May 2, 2017 Capital Cube
12:24PM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: 2016 By the Numbers : May 2, 2017 Capital Cube
Apr-24-17 04:05PM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Apr-17-17 04:03PM  Avadel Pharmaceuticals to Report First Quarter 2017 Results GlobeNewswire
Apr-01-17 01:04PM  AVADEL PHARMACEUTICALS PLC Financials
Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines in the United States, France, and Ireland. Its commercial products that are used in the hospital setting include Bloxiverz, a drug used in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; Vazculep, a phenylephrine hydrochloride injection that is used for the treatment of hypotension occurring in the setting of anesthesia; and Akovaz, an ephedrine sulfate injection for treating hypotension, as well as Noctiva for treating nocturia due to nocturnal polyuria. The company owns and develops drug delivery platforms, such as Micropump, a microparticulate system that allows the development of modified and/or controlled release of solid and oral dosage formulations of drugs; LiquiTime, which allows development of modified/controlled release liquid suspension formulations; Trigger Lock that allows development of abuse-resistant modified/controlled release formulations of narcotic/opioid analgesics and other drugs susceptible to abuse; and Medusa, a hydrogel depot technology that allows the development of extended/modified release of injectable dosage formulations of drugs. Its product candidates also comprise REST-ON, which is in Phase III clinical trial for the treatment of daytime sleepiness and cataplexy in patients suffering from narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. The company was founded in 1990 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KANAN MICHAEL FSee RemarksDec 14Sale2.498,42921,02229,538Dec 18 04:06 PM
GUSKY DAVID PController & CAODec 14Sale2.686171,6564,083Dec 18 04:04 PM
Hatten Sandra LSee RemarksDec 14Sale2.583,1738,18340,837Dec 18 04:01 PM
Hatten Sandra LSee RemarksAug 10Sale4.916,29030,85944,010Aug 14 08:00 PM
ANDERSON MICHAEL SChief Executive OfficerAug 10Sale4.9116,29779,953248,953Aug 14 08:01 PM
ANDERSON MICHAEL SChief Executive OfficerJun 26Buy6.042,50015,100265,250Jun 27 07:02 PM
DIVIS GREG JSee RemarksJun 26Buy6.0016,00096,00049,100Jun 27 07:00 PM
THOMPSON PHILLANDAS T.See RemarksJun 26Buy5.7710,00057,70091,000Jun 27 06:58 PM
KANAN MICHAEL FSee RemarksJun 26Buy5.701,96711,21237,967Jun 29 05:24 PM
Flynn James E10% OwnerJun 25Sale5.99114,034683,315952,265Jun 25 05:59 PM
ANDERSON MICHAEL SChief Executive OfficerMay 24Buy6.443,00019,320262,750May 29 05:15 PM